Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
58%
Parkinson
41%
Levodopa-induced Dyskinesia
37%
Dopaminergic Pathway
25%
Risk Variant
25%
5-flucytosine
18%
SARS-CoV-2 Infection
15%
Immune Response
15%
COVID-19
15%
GBA1
14%
Clinical Data
14%
Luxembourgish
14%
Sustained Release Pellets
12%
Disease Duration
12%
Long-read Sequencing
12%
Cardiovascular History
12%
Prognostic Analysis
12%
Cross-cohort
12%
Authorship Criteria
12%
Metabolomics Data
12%
Outcome Prediction
12%
Gait Data
12%
Polygenic Background
12%
Mild Cognitive Impairment
12%
Cardiovascular Risk
12%
Xanthine Metabolism
12%
Predictors of Cognitive Impairment
12%
Cryptococcal Meningitis
12%
Pellet Formulation
12%
Idiopathic PD
12%
Gut Microbiota
12%
Memory Impairment
12%
Variant Carriers
12%
Idiopathic Parkinson's Disease
12%
Major Risk
12%
Health Effects
12%
Longitudinal Analysis
12%
Coronavirus Disease (COVID)
12%
Cross-sectional Observational Study
12%
System Analysis
12%
Post-COVID
12%
Risk Factors
12%
Machine Learning
12%
DNA Methylation (DNAm)
12%
Population-based Cohort
12%
Epigenetic Modification
12%
Methylation Landscape
12%
Post SARS-CoV-2
12%
Luxembourg
11%
Differentially Methylated Positions
7%
Differentially Methylated Regions
7%
Acute Phase
7%
95% Confidence Interval
7%
Family History
6%
RIKEN
6%
Expert Support
6%
Non-carriers
6%
Lack of Sleep
6%
Andr
6%
History of Cardiovascular Disease
6%
Research Fund
6%
Biorepository
6%
Parkinson's Disease-mild Cognitive Impairment
6%
Pathogenic Variants
6%
High Risk
5%
Gut Microbiota Composition
5%
GNA12
5%
IFI44L
5%
DNA Methylation Changes
5%
Age of Infection
5%
Medicine and Dentistry
Parkinson's Disease
63%
Gait
28%
Metabolomics
25%
Education
15%
Gut Microbiome
12%
Infection
12%
Mild Cognitive Impairment
12%
Observational Study
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
COVID-19
12%
Quality of Sleep
12%
Insulin Dependent Diabetes Mellitus
12%
Glycemic Control
12%
Glucose
12%
Dopamine
12%
Levodopa-Induced Dyskinesia
12%
Cardiovascular System
12%
Comorbidity
10%
Prevalence
7%
Quality of Life
7%
Insulin Pump
7%
Arm
7%
Cardiovascular Disease
7%
Stereotypic Movement Disorder
6%
Diseases
5%
Unified Parkinson's Disease Rating Scale
5%
Levodopa
5%
Capillary Blood
5%
Psychological Well-Being
5%
Prematurity
5%
Cerebrovascular Disease
5%
Lipid
5%
Neuroscience
Parkinson's Disease
100%
L-DOPA
37%
Dyskinesia
37%
Mild Cognitive Impairment
28%
Gut Microbiome
25%
Dopamine
25%
Risk Factor
17%
Comorbidity
16%
Progressive Supranuclear Palsy
12%
MicroRNA
12%
Memory Disorder
12%
Cognitive Disorders
12%
Gait
12%
Cardiovascular System
12%
SARS Coronavirus
6%
Subjective Cognitive Decline
6%
Stereotypic Movement Disorder
5%